PWM
CRL icon

Perigon Wealth Management’s Charles River Laboratories CRL Stock Holding History

Perigon Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,500
Closed -$201K – 274
2015
Q4 		$201K Buy
+2,500
New +$180K 0.06% 216

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Perigon Wealth Management's CRL Position: Q1 2016 in Review

Perigon Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2016, closing a stake of 2,500 shares — an estimated $201K sold.

Perigon Wealth Management first reported a position in CRL in Q4 2015 and held it in 1 quarter. The position peaked at $201K in Q4 2015. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

  • Perigon Wealth Management reported no remaining Charles River Laboratories position as of Q1 2016 after selling out during the quarter.
  • Perigon Wealth Management sold 2,500 Charles River Laboratories shares in Q1 2016, an estimated $201K.
  • Perigon Wealth Management first reported a position in Charles River Laboratories in Q4 2015 and held it in 1 quarter.
  • Perigon Wealth Management's Charles River Laboratories position peaked at $201K in Q4 2015.
  • 264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on Perigon Wealth Management's 13F filing for Q1 2016, filed 3 Jun 2016.